Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 20;14(1):103.
doi: 10.3390/brainsci14010103.

Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug

Affiliations
Review

Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug

Liliana Dell'Osso et al. Brain Sci. .

Abstract

The current literature globally highlights the efficacy of Clozapine in several psychiatric disorders all over the world, with an FDA indication for reducing the risk of repeated suicidal behavior in patients with schizophrenia or schizoaffective disorder. A growing field of research is also stressing a possible broader beneficial effect of Clozapine in promoting neuroprotection and neurotrophism. However, this drug is linked to several life-threatening side effects, such as agranulocytosis, myocarditis and seizures, that limit its use in daily clinical practice. For this work, a search was performed on PubMed using the terms "Clozapine indications", "Clozapine adverse effects", "Clozapine regenerative effects", and "Clozapine neuroplasticity" with the aim of reviewing the scientific literature on Clozapine's treatment indications, adverse effects and potential regenerative role. The results confirmed the efficacy of clozapine in clinical practice, although limited by its adverse effects. It appears crucial to raise awareness among clinicians about the potential benefits of using Clozapine, as well educating medical personnel about its risks and the early identification of possible adverse effects and their management.

Keywords: Clozapine; adverse effects; regenerative effects; treatment indications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Shen W.W. A history of antipsychotic drug development. Compr. Psychiatry. 1999;40:407–414. doi: 10.1016/S0010-440X(99)90082-2. - DOI - PubMed
    1. Crilly J. The history of clozapine and its emergence in the US market: A review and analysis. Hist. Psychiatry. 2007;18:39–60. doi: 10.1177/0957154X07070335. - DOI - PubMed
    1. Tamminga C.A. Treatment mechanisms: Traditional and new antipsychotic drugs. Dialog. Clin. Neurosci. 2000;2:281–286. doi: 10.31887/DCNS.2000.2.3/ctamminga. - DOI - PMC - PubMed
    1. Nucifora F.C., Jr., Mihaljevic M., Lee B.J., Sawa A. Clozapine as a Model for Antipsychotic Development. Neurotherapeutics. 2017;14:750–761. doi: 10.1007/s13311-017-0552-9. - DOI - PMC - PubMed
    1. Hippius H. The history of clozapine. Psychopharmacology. 1989;99((Suppl. S3)):S3–S5. doi: 10.1007/BF00442551. - DOI - PubMed

LinkOut - more resources